Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis–Associated Interstitial Lung Disease
International Journal of Molecular Sciences · 05.04.2023 · 24 (7) · 6800
DOI: 10.3390/ijms24076800 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.04.2023. Verfasst von Natalia Mena-Vázquez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación Biomédica de Málaga (IBIMA)-Plataforma Bionand, 29010 Málaga, Spain. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Lung Diseases, Interstitial. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundacion Andaluza de Reumatologia, Universidad de Malaga, Instituto de salud carlos III.
Abstract (Originalsprache)
This study aimed to identify inflammatory factors and soluble cytokines that act as biomarkers in the diagnosis and prognosis of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). We performed a nested prospective observational case–control study of patients with RA-ILD matched by sex, age, and time since the diagnosis of RA. All participants underwent pulmonary function testing and high-resolution computed tomography. ILD was defined according to the criteria of the American Thoracic Society/European Respiratory Society; the progression of lung disease was defined as the worsening of FVC > 10% or DLCO > 15%. Inflammation-related variables included the inflammatory activity measured using the DAS28-ESR and a multiplex cytokine assay. Two Cox regression models were run to identify factors associated with ILD and the progression of ILD. The study population comprised 70 patients: 35 patients with RA-ILD (cases) and 35 RA patients without ILD (controls). A greater percentage of cases had higher DAS28-ESR (p = 0.032) and HAQ values (p = 0.003). The variables associated with RA-ILD in the Cox regression analysis were disease activity (DAS28) (HR [95% CI], 2.47 [1.17–5.22]; p = 0.017) and high levels of ACPA (HR [95% CI], 2.90 [1.24–6.78]; p = 0.014), IL-18 in pg/mL (HR [95% CI], 1.06 [1.00–1.12]; p = 0.044), MCP-1/CCL2 in pg/mL (HR [95% CI], 1.03 [1.00–1.06]; p = 0.049), and SDF-1 in pg/mL (HR [95% CI], 1.00 [1.00–1.00]; p = 0.010). The only variable associated with the progression of ILD was IL-18 in pg/mL (HR [95% CI], 1.25 [1.07–1.46]; p = 0.004). Our data support that the inflammatory activity was higher in patients with RA-ILD than RA patients without ILD. Some cytokines were associated with both diagnosis and poorer prognosis in patients with RA-ILD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Investigación Biomédica de Málaga (IBIMA)-Plataforma Bionand, 29010 Málaga, Spain.
- UGC de Reumatología, Hospital Regional Universitario de Málaga, 29009 Málaga, Spain.
- UGC de Reumatología, Hospital Universitario de Jaén, 23007 Jaén, Spain.
- Departamento de Medicina y Dermatología, Universidad de Málaga, 29010 Málaga, Spain.
- UGC de Endocrinología y Nutrición, Hospital Clínico Virgen de la Victoria, 29010 Málaga, Spain.
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
ORCID-Profile: Natalia Mena-Vázquez, Jose Manuel Lisbona-Montañez, Sara Manrique-Arija, José Rioja, Arkaitz Mucientes, Patricia Ruiz-Limón, Begoña Oliver-Martos, Antonio Fernández-Nebro
Förderung
- Fundacion Andaluza de Reumatologia
- Universidad de Malaga
- Instituto de salud carlos III
- FAR (Fundación Andaluza de Reumatología)
- “Ayuda de Garantía Juvenil 2020” of the University of Malaga, Spain
- Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), Red de Enfermedades Inflamatorias (REI)
- “Sara Borrell” postdoctoral contract
- “Rio Hortega” contract
Zitieren
APA
Mena-Vázquez, N., Godoy-Navarrete, F. J., Lisbona-Montañez, J. M., Redondo-Rodriguez, R., Manrique-Arija, S., Rioja, J., Mucientes, A., Ruiz-Limón, P., Garcia-Studer, A., Ortiz-Márquez, F., Oliver-Martos, B., Cano-García, L., & Fernández-Nebro, A. (2023). Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis–Associated Interstitial Lung Disease. International Journal of Molecular Sciences, 24(7), 6800. https://doi.org/10.3390/ijms24076800
Vancouver
Mena-Vázquez N, Godoy-Navarrete FJ, Lisbona-Montañez JM, Redondo-Rodriguez R, Manrique-Arija S, Rioja J, et al. Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis–Associated Interstitial Lung Disease. International Journal of Molecular Sciences. 2023;24(7):6800. doi:10.3390/ijms24076800
BibTeX
@article{MenaVzquez2023,
author = {Mena-Vázquez, Natalia and Godoy-Navarrete, Francisco Javier and Lisbona-Montañez, Jose Manuel and Redondo-Rodriguez, Rocío and Manrique-Arija, Sara and Rioja, José and Mucientes, Arkaitz and Ruiz-Limón, Patricia and Garcia-Studer, Aimara and Ortiz-Márquez, Fernando and Oliver-Martos, Begoña and Cano-García, Laura and Fernández-Nebro, Antonio},
title = {Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis–Associated Interstitial Lung Disease},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {7},
pages = {6800},
doi = {10.3390/ijms24076800}
}
EUVIMED